Analysis of induced pluripotent stem cells carrying 22q11.2 deletion

M. Toyoshima, W. Akamatsu, Y. Okada, T. Ohnishi, S. Balan, Y. Hisano, Y. Iwayama, T. Toyota, T. Matsumoto, N. Itasaka, S. Sugiyama, M. Tanaka, M. Yano, B. Dean, Hideyuki Okano, T. Yoshikawa

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Given the complexity and heterogeneity of the genomic architecture underlying schizophrenia, molecular analyses of these patients with defined and large effect-size genomic defects could provide valuable clues. We established human-induced pluripotent stem cells from two schizophrenia patients with the 22q11.2 deletion (two cell lines from each subject, total of four cell lines) and three controls (total of four cell lines). Neurosphere size, neural differentiation efficiency, neurite outgrowth, cellular migration and the neurogenic-to-gliogenic competence ratio were significantly reduced in patient-derived cells. As an underlying mechanism, we focused on the role of DGCR8, a key gene for microRNA (miRNA) processing and mapped in the deleted region. In mice, Dgcr8 hetero-knockout is known to show a similar phenotype of reduced neurosphere size (Ouchi et al., 2013). The miRNA profiling detected reduced expression levels of miRNAs belonging to miR-17/92 cluster and miR-106a/b in the patient-derived neurospheres. Those miRNAs are reported to target p38α, and conformingly the levels of p38α were upregulated in the patient-derived cells. p38α is known to drive gliogenic differentiation. The inhibition of p38 activity by SB203580 in patient-derived neurospheres partially restored neurogenic competence. Furthermore, we detected elevated expression of GFAP, a gliogenic (astrocyte) marker, in postmortem brains from schizophrenia patients without the 22q11.2 deletion, whereas inflammation markers (IL1B and IL6) remained unchanged. In contrast, a neuronal marker, MAP2 expressions were decreased in schizophrenia brains. These results suggest that a dysregulated balance of neurogenic-to-gliogenic competence may underlie neurodevelopmental disorders such as schizophrenia.

Original languageEnglish
Article numbere934
JournalTranslational Psychiatry
Volume6
Issue number11
DOIs
Publication statusPublished - 2016 Nov 1

Fingerprint

Induced Pluripotent Stem Cells
Schizophrenia
MicroRNAs
Mental Competency
Cell Line
Brain
Astrocytes
Interleukin-6
Inflammation
Efficiency
Phenotype
Genes

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Toyoshima, M., Akamatsu, W., Okada, Y., Ohnishi, T., Balan, S., Hisano, Y., ... Yoshikawa, T. (2016). Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. Translational Psychiatry, 6(11), [e934]. https://doi.org/10.1038/tp.2016.206

Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. / Toyoshima, M.; Akamatsu, W.; Okada, Y.; Ohnishi, T.; Balan, S.; Hisano, Y.; Iwayama, Y.; Toyota, T.; Matsumoto, T.; Itasaka, N.; Sugiyama, S.; Tanaka, M.; Yano, M.; Dean, B.; Okano, Hideyuki; Yoshikawa, T.

In: Translational Psychiatry, Vol. 6, No. 11, e934, 01.11.2016.

Research output: Contribution to journalArticle

Toyoshima, M, Akamatsu, W, Okada, Y, Ohnishi, T, Balan, S, Hisano, Y, Iwayama, Y, Toyota, T, Matsumoto, T, Itasaka, N, Sugiyama, S, Tanaka, M, Yano, M, Dean, B, Okano, H & Yoshikawa, T 2016, 'Analysis of induced pluripotent stem cells carrying 22q11.2 deletion', Translational Psychiatry, vol. 6, no. 11, e934. https://doi.org/10.1038/tp.2016.206
Toyoshima M, Akamatsu W, Okada Y, Ohnishi T, Balan S, Hisano Y et al. Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. Translational Psychiatry. 2016 Nov 1;6(11). e934. https://doi.org/10.1038/tp.2016.206
Toyoshima, M. ; Akamatsu, W. ; Okada, Y. ; Ohnishi, T. ; Balan, S. ; Hisano, Y. ; Iwayama, Y. ; Toyota, T. ; Matsumoto, T. ; Itasaka, N. ; Sugiyama, S. ; Tanaka, M. ; Yano, M. ; Dean, B. ; Okano, Hideyuki ; Yoshikawa, T. / Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. In: Translational Psychiatry. 2016 ; Vol. 6, No. 11.
@article{1af4980efc284a3d89085fd544d9b497,
title = "Analysis of induced pluripotent stem cells carrying 22q11.2 deletion",
abstract = "Given the complexity and heterogeneity of the genomic architecture underlying schizophrenia, molecular analyses of these patients with defined and large effect-size genomic defects could provide valuable clues. We established human-induced pluripotent stem cells from two schizophrenia patients with the 22q11.2 deletion (two cell lines from each subject, total of four cell lines) and three controls (total of four cell lines). Neurosphere size, neural differentiation efficiency, neurite outgrowth, cellular migration and the neurogenic-to-gliogenic competence ratio were significantly reduced in patient-derived cells. As an underlying mechanism, we focused on the role of DGCR8, a key gene for microRNA (miRNA) processing and mapped in the deleted region. In mice, Dgcr8 hetero-knockout is known to show a similar phenotype of reduced neurosphere size (Ouchi et al., 2013). The miRNA profiling detected reduced expression levels of miRNAs belonging to miR-17/92 cluster and miR-106a/b in the patient-derived neurospheres. Those miRNAs are reported to target p38α, and conformingly the levels of p38α were upregulated in the patient-derived cells. p38α is known to drive gliogenic differentiation. The inhibition of p38 activity by SB203580 in patient-derived neurospheres partially restored neurogenic competence. Furthermore, we detected elevated expression of GFAP, a gliogenic (astrocyte) marker, in postmortem brains from schizophrenia patients without the 22q11.2 deletion, whereas inflammation markers (IL1B and IL6) remained unchanged. In contrast, a neuronal marker, MAP2 expressions were decreased in schizophrenia brains. These results suggest that a dysregulated balance of neurogenic-to-gliogenic competence may underlie neurodevelopmental disorders such as schizophrenia.",
author = "M. Toyoshima and W. Akamatsu and Y. Okada and T. Ohnishi and S. Balan and Y. Hisano and Y. Iwayama and T. Toyota and T. Matsumoto and N. Itasaka and S. Sugiyama and M. Tanaka and M. Yano and B. Dean and Hideyuki Okano and T. Yoshikawa",
year = "2016",
month = "11",
day = "1",
doi = "10.1038/tp.2016.206",
language = "English",
volume = "6",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Analysis of induced pluripotent stem cells carrying 22q11.2 deletion

AU - Toyoshima, M.

AU - Akamatsu, W.

AU - Okada, Y.

AU - Ohnishi, T.

AU - Balan, S.

AU - Hisano, Y.

AU - Iwayama, Y.

AU - Toyota, T.

AU - Matsumoto, T.

AU - Itasaka, N.

AU - Sugiyama, S.

AU - Tanaka, M.

AU - Yano, M.

AU - Dean, B.

AU - Okano, Hideyuki

AU - Yoshikawa, T.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Given the complexity and heterogeneity of the genomic architecture underlying schizophrenia, molecular analyses of these patients with defined and large effect-size genomic defects could provide valuable clues. We established human-induced pluripotent stem cells from two schizophrenia patients with the 22q11.2 deletion (two cell lines from each subject, total of four cell lines) and three controls (total of four cell lines). Neurosphere size, neural differentiation efficiency, neurite outgrowth, cellular migration and the neurogenic-to-gliogenic competence ratio were significantly reduced in patient-derived cells. As an underlying mechanism, we focused on the role of DGCR8, a key gene for microRNA (miRNA) processing and mapped in the deleted region. In mice, Dgcr8 hetero-knockout is known to show a similar phenotype of reduced neurosphere size (Ouchi et al., 2013). The miRNA profiling detected reduced expression levels of miRNAs belonging to miR-17/92 cluster and miR-106a/b in the patient-derived neurospheres. Those miRNAs are reported to target p38α, and conformingly the levels of p38α were upregulated in the patient-derived cells. p38α is known to drive gliogenic differentiation. The inhibition of p38 activity by SB203580 in patient-derived neurospheres partially restored neurogenic competence. Furthermore, we detected elevated expression of GFAP, a gliogenic (astrocyte) marker, in postmortem brains from schizophrenia patients without the 22q11.2 deletion, whereas inflammation markers (IL1B and IL6) remained unchanged. In contrast, a neuronal marker, MAP2 expressions were decreased in schizophrenia brains. These results suggest that a dysregulated balance of neurogenic-to-gliogenic competence may underlie neurodevelopmental disorders such as schizophrenia.

AB - Given the complexity and heterogeneity of the genomic architecture underlying schizophrenia, molecular analyses of these patients with defined and large effect-size genomic defects could provide valuable clues. We established human-induced pluripotent stem cells from two schizophrenia patients with the 22q11.2 deletion (two cell lines from each subject, total of four cell lines) and three controls (total of four cell lines). Neurosphere size, neural differentiation efficiency, neurite outgrowth, cellular migration and the neurogenic-to-gliogenic competence ratio were significantly reduced in patient-derived cells. As an underlying mechanism, we focused on the role of DGCR8, a key gene for microRNA (miRNA) processing and mapped in the deleted region. In mice, Dgcr8 hetero-knockout is known to show a similar phenotype of reduced neurosphere size (Ouchi et al., 2013). The miRNA profiling detected reduced expression levels of miRNAs belonging to miR-17/92 cluster and miR-106a/b in the patient-derived neurospheres. Those miRNAs are reported to target p38α, and conformingly the levels of p38α were upregulated in the patient-derived cells. p38α is known to drive gliogenic differentiation. The inhibition of p38 activity by SB203580 in patient-derived neurospheres partially restored neurogenic competence. Furthermore, we detected elevated expression of GFAP, a gliogenic (astrocyte) marker, in postmortem brains from schizophrenia patients without the 22q11.2 deletion, whereas inflammation markers (IL1B and IL6) remained unchanged. In contrast, a neuronal marker, MAP2 expressions were decreased in schizophrenia brains. These results suggest that a dysregulated balance of neurogenic-to-gliogenic competence may underlie neurodevelopmental disorders such as schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=84994234202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994234202&partnerID=8YFLogxK

U2 - 10.1038/tp.2016.206

DO - 10.1038/tp.2016.206

M3 - Article

C2 - 27801899

AN - SCOPUS:84994234202

VL - 6

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 11

M1 - e934

ER -